Galera Therapeutics Inc

Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel, proprietary therapeutics to transform radiotherapy in cancer. The company's product candidate is GC4419, a highly selective and potent small molecule dismutase mimetic which is designed to rapidly convert superoxide to hydrogen peroxide. Galera Therapeutics, Inc. is headquartered in Malvern, PA.

Address Details

Address: 2 WEST LIBERTY BOULEVARD SUITE 100

City: MALVERN

State: PA

Country: USA

Zip Code: 19355